Search results for Lamivudine

407 hits were found for Lamivudine

# Family MCID Name MIFTS Score
1
c HPT016 Hepatitis B 59 1.156
2
HMN044 Human Immunodeficiency Virus Type 1 71 0.787
3
HMN014 Human Immunodeficiency Virus Infectious Disease 55 0.730
4
48X005 48,xyyy 39 0.674
5
P HPT021 Hepatitis 67 0.591
6
ACQ007 Acquired Immunodeficiency Syndrome 60 0.521
7
IMM167 Immune Deficiency Disease 78 0.494
8
LVR012 Liver Cirrhosis 62 0.427
9
c HPT003 Hepatitis a 62 0.410
10
P LVR013 Liver Disease 68 0.320
11
c RHB024 Rhabdomyosarcoma 2 67 0.312
12
HRP008 Herpes Simiae 25 0.310
13
CHL079 Children's Interstitial Lung Disease 26 0.267
14
CMR002 Coumarin Resistance 56 0.248
15
P HPT023 Hepatocellular Carcinoma 100 0.217
16
MND021 Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome 65 0.191
17
P EXN002 Exanthem 57 0.180
18
c VRL010 Viral Hepatitis 52 0.168
19
ATX019 Ataxia with Vitamin E Deficiency 42 0.168
20
P MYC084 Mycobacterium Tuberculosis 1 68 0.165
21
c ACT134 Acute Liver Failure 56 0.155
22
HPT004 Hepatic Coma 45 0.155
23
VRL011 Viral Infectious Disease 61 0.152
24
HPT019 Hepatic Encephalopathy 60 0.145
25
c HPT015 Hepatitis D 49 0.141
26
PPL061 Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome 25 0.141
27
P CNR004 Cone-Rod Dystrophy 2 73 0.133
28
P KDN018 Kidney Disease 72 0.133
29
ADL002 Adult Syndrome 70 0.133
30
c NRD033 Neurodegeneration with Brain Iron Accumulation 2a 69 0.129
31
LYM133 Lymphoma, Hodgkin, Classic 69 0.129
32
P GLM007 Glomerulonephritis 57 0.129
33
BLR008 Bilirubin Metabolic Disorder 57 0.129
34
P LCT001 Lactic Acidosis 51 0.129
35
PLC008 Placenta Disease 50 0.125
36
LYM143 Lymphoma, Non-Hodgkin, Familial 72 0.121
37
P BCL017 B-Cell Lymphoma 58 0.121
38
P PRP019 Peripheral Nervous System Disease 58 0.121
39
P NRP001 Neuropathy 56 0.121
40
P DRR001 Diarrhea 55 0.121
41
SHR059 Short Stature, Onychodysplasia, Facial Dysmorphism, and Hypotrichosis 47 0.121
42
DFC004 Deficiency Anemia 70 0.117
43
P TRN020 Turner Syndrome 67 0.117
44
c FNC043 Fanconi Anemia, Complementation Group E 62 0.117
45
ALL026 Allergic Hypersensitivity Disease 62 0.117
46
P PLY017 Polyarteritis Nodosa 58 0.117
47
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 57 0.117
48
c HPT073 Hepatitis C Virus 72 0.112
49
P NPH012 Nephrotic Syndrome 60 0.112
50
c HPT001 Hepatitis C 62 0.107
51
P CRD246 Cardiovascular System Disease 57 0.107
52
P MMB011 Membranous Nephropathy 50 0.107
53
P LYM118 Lymphoma 68 0.102
54
P VSC011 Vasculitis 62 0.102
55
c INF145 Infantile Liver Failure Syndrome 1 50 0.102
56
LYM019 Lymphosarcoma 46 0.102
57
c PRM038 Primary Agammaglobulinemia 44 0.102
58
P PRT133 Proteasome-Associated Autoinflammatory Syndrome 1 81 0.097
59
P ENC018 Encephalopathy 61 0.097
60
P PNC044 Pancreatitis 61 0.097
61
MLT161 Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly 57 0.097
62
49X006 49, Xxxxy Syndrome 41 0.097
63
ANM044 Anemia, X-Linked, with or Without Neutropenia and/or Platelet Abnormalities 67 0.091
64
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 47 0.091
65
c DRR009 Diarrhea 6 46 0.091
66
c LKM005 Leukemia, T-Cell, Chronic 34 0.091
67
PLM001 Pulmonary Tuberculosis 69 0.086
68
NTR005 Nutritional Deficiency Disease 62 0.086
69
c ACT027 Acute Pancreatitis 60 0.086
70
P ALC033 Alcohol Use Disorder 58 0.086
71
DFF005 Diffuse Large B-Cell Lymphoma 55 0.086
72
ENC067 Encephalopathy, Progressive, Early-Onset, with Episodic Rhabdomyolysis 55 0.086
73
END086 End Stage Renal Disease 51 0.086
74
HYP017 Hypophosphatemia 50 0.086
75
47X002 47,xyy 49 0.086
76
c HMN021 Human T-Cell Leukemia Virus Type 1 47 0.086
77
P LKM071 Leukemia, Chronic Lymphocytic 79 0.079
78
c HYP836 Hypercholesterolemia, Familial, 1 73 0.079
79
c MCL062 Mucolipidosis Ii Alpha/beta 68 0.079
80
P NRV007 Nervous System Disease 66 0.079
81
P NTR004 Neutropenia 63 0.079
82
P FTT008 Fatty Liver Disease, Nonalcoholic 1 60 0.079
83
c HPT007 Hepatitis E 53 0.079
84
c CNT035 Central Nervous System Disease 52 0.079
85
PRM127 Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type 38 0.079
86
MLR004 Malaria 81 0.072
87
P MYP004 Myopathy 70 0.072
88
P PNM007 Pneumonia 68 0.072
89
P MNN013 Meningitis 66 0.072
90
P VSC007 Vascular Disease 63 0.072
91
LPD008 Lipid Metabolism Disorder 62 0.072
92
INT324 Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, and Genital Anomalies 58 0.072
93
GLC003 Glucose Intolerance 54 0.072
94
OCL069 Ocular Motor Apraxia 51 0.072
95
TRP002 Tropical Spastic Paraparesis 50 0.072
96
MYL057 Myelopathy, Htlv-1-Associated 39 0.072
97
HTL001 Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis 35 0.072
98
P CLR023 Colorectal Cancer 99 0.065
99
P OST002 Osteoporosis 74 0.065
100
ANX010 Anxiety 73 0.065
101
P MYC007 Myocardial Infarction 70 0.065
102
DWN001 Down Syndrome 70 0.065
103
P LKM002 Leukemia 68 0.065
104
ALC007 Alcohol Dependence 66 0.065
105
TTN003 Tetanus 65 0.065
106
P ART062 Arthrogryposis, Renal Dysfunction, and Cholestasis 1 65 0.065
107
ART002 Arts Syndrome 64 0.065
108
LYM017 Lyme Disease 64 0.065
109
ATM095 Autoimmune Disease 62 0.065
110
P PRM006 Primary Biliary Cirrhosis 62 0.065
111
P BND020 Bone Disease 59 0.065
112
PNM001 Pneumocystosis 59 0.065
113
P ADL017 Adult T-Cell Leukemia 56 0.065
114
AGN016 Aging 56 0.065
115
c FML035 Familial Hyperlipidemia 55 0.065
116
MNN032 Meningococcal Meningitis 54 0.065
117
HPT014 Hepatorenal Syndrome 50 0.065
118
STM007 Stomatitis 50 0.065
119
CRY014 Cryptococcal Meningitis 48 0.065
120
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 0.065
121
P PRR002 Pure Red-Cell Aplasia 47 0.065
122
NSS002 Neisseria Meningitidis Infection 47 0.065
123
MNN020 Meningococcal Infection 46 0.065
124
c HYP272 Hypercholesterolemia, Familial, 3 44 0.065
125
RDC006 Red Cell Aplasia 43 0.065
126
PLY068 Polysubstance Abuse 43 0.065
127
CYT002 Cytokine Deficiency 42 0.065
128
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 42 0.065
129
PST092 Posttransplant Acute Limbic Encephalitis 29 0.065
130
c HYP595 Hypertension, Essential 84 0.056
131
STR067 Stroke, Ischemic 81 0.056
132
P BDY004 Body Mass Index Quantitative Trait Locus 11 76 0.056
133
KPS004 Kaposi Sarcoma 75 0.056
134
P HRT032 Heart Disease 75 0.056
135
c ATR087 Atrial Standstill 1 75 0.056
136
P APL001 Aplastic Anemia 74 0.056
137
P HYP724 Hyperlipoproteinemia, Type Iii 73 0.056
138
PRP027 Peripheral Vascular Disease 71 0.056
139
c CHR684 Chronic Kidney Disease 70 0.056
140
FCT007 Factor Vii Deficiency 67 0.056
141
CRB039 Cerebrovascular Disease 67 0.056
142
SRC014 Sarcoma 65 0.056
143
P CRN300 Coronary Heart Disease 1 63 0.056
144
DPR016 Depression 63 0.056
145
3HY005 3-Hydroxyacyl-Coa Dehydrogenase Deficiency 62 0.056
146
LPP008 Lipoprotein Quantitative Trait Locus 62 0.056
147
P HYP750 Hypertriglyceridemia, Familial 62 0.056
148
NNL005 Non-Alcoholic Fatty Liver Disease 61 0.056
149
VRC005 Varicose Veins 60 0.056
150
P SLP005 Sleep Disorder 59 0.056
151
CRY005 Cryptococcosis 58 0.056
152
RBS001 Rabies 58 0.056
153
MNT002 Mental Depression 58 0.056
154
P MYS005 Myositis 56 0.056
155
c LKM060 Leukemia, Acute Lymphoblastic 3 56 0.056
156
BCT022 Bacterial Infectious Disease 56 0.056
157
SPN041 Spinal Cord Disease 56 0.056
158
SFT003 Soft Tissue Sarcoma 56 0.056
159
NPH009 Nephrolithiasis 55 0.056
160
P ALP008 Alopecia 54 0.056
161
HRT012 Heart Valve Disease 53 0.056
162
SPN035 Spindle Cell Sarcoma 53 0.056
163
TXC002 Toxic Encephalopathy 53 0.056
164
ACR041 Acromelic Frontonasal Dysostosis 52 0.056
165
c BDY021 Body Mass Index Quantitative Trait Locus 20 52 0.056
166
ART140 Arteries, Anomalies of 52 0.056
167
c BDY020 Body Mass Index Quantitative Trait Locus 19 52 0.056
169
P FNC004 Fanconi Syndrome 50 0.056
170
MNN009 Meningoencephalitis 49 0.056
171
BNR002 Bone Resorption Disease 48 0.056
172
IGG001 Iga Glomerulonephritis 48 0.056
173
VSC058 Vasculitis, Autoinflammation, Immunodeficiency, and Hematologic Defects Syndrome 48 0.056
174
c BDY005 Body Mass Index Quantitative Trait Locus 9 48 0.056
175
CRY008 Cryopyrin-Associated Periodic Syndrome 47 0.056
176
KRT002 Keratomalacia 47 0.056
177
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 0.056
178
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.056
179
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.056
180
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.056
181
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.056
182
c BDY006 Body Mass Index Quantitative Trait Locus 8 44 0.056
183
c BDY012 Body Mass Index Quantitative Trait Locus 7 44 0.056
184
MRG013 Mirage Syndrome 43 0.056
185
DRG024 Drug Allergy 42 0.056
186
CTS005 Catastrophic Antiphospholipid Syndrome 42 0.056
187
GST020 Gastric Antral Vascular Ectasia 41 0.056
188
PRS063 Paresthesia 41 0.056
189
P MLG074 Malignant Mesenchymoma 40 0.056
190
CRD017 Cardiac Valvular Dysplasia, X-Linked 40 0.056
191
P FNC034 Fanconi Renotubular Syndrome 2 40 0.056
192
GLC008 Glucose Metabolism Disease 40 0.056
193
RPD005 Rapidly Involuting Congenital Hemangioma 38 0.056
194
PRG080 Progressive Non-Infectious Anterior Vertebral Fusion 35 0.056
195
CYT018 Cytochrome P450 2d6 Variant 27 0.056
196
c SYS066 Systemic Polyarteritis Nodosa 26 0.056
197
JVN026 Jeavons Syndrome 24 0.056
198
c LKM061 Leukemia, Acute Myeloid 84 0.046
199
P RHM011 Rheumatoid Arthritis 80 0.046
200
CRH001 Crohn's Disease 74 0.046
201
P GRF003 Graft-Versus-Host Disease 72 0.046
202
P OCL013 Oculodentodigital Dysplasia 69 0.046
203
P INF038 Influenza 68 0.046
204
c HMP004 Hemophilia B 68 0.046
205
RCK004 Rickets 68 0.046
206
P THR014 Thrombocytopenia 67 0.046
207
P FLL037 Follicular Lymphoma 67 0.046
208
c HMP029 Hemophilia a 67 0.046
209
P HYP098 Hypereosinophilic Syndrome 67 0.046
210
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 66 0.046
211
P DMN002 Dementia 66 0.046
212
KHL003 Kohlschutter-Tonz Syndrome 65 0.046
213
P ABD014 Abdominal Obesity-Metabolic Syndrome 1 64 0.046
214
P ACR001 Aicardi-Goutieres Syndrome 62 0.046
215
CHL068 Cholestasis 61 0.046
216
DRM006 Dermatitis 61 0.046
217
c ACT071 Acute Kidney Failure 60 0.046
218
c ALB021 Albinism, Oculocutaneous, Type Ii 59 0.046
219
PRT013 Portal Hypertension 59 0.046
220
SNS008 Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis 59 0.046
221
P SYP003 Syphilis 58 0.046
222
GLB001 Gilbert Syndrome 58 0.046
223
ISC004 Ischemia 58 0.046
224
CNT047 Contact Dermatitis 58 0.046
225
P URT039 Urticaria 58 0.046
226
GLS018 Glass Syndrome 57 0.046
227
IRN002 Iron Metabolism Disease 57 0.046
228
SCH014 Schistosomiasis 57 0.046
229
HYP266 Hypoxia 57 0.046
230
P ANG015 Angioedema 57 0.046
231
HMT008 Hematuria, Benign Familial 56 0.046
232
P GST044 Gastritis 56 0.046
233
P PLM034 Pulmonary Emphysema 55 0.046
234
PRP030 Purpura 54 0.046
235
PRT038 Protein-Energy Malnutrition 54 0.046
236
HMS001 Hemosiderosis 54 0.046
237
PLS007 Plasmodium Falciparum Malaria 52 0.046
238
c ACR116 Aicardi-Goutieres Syndrome 1 52 0.046
239
P HMP007 Hemophilia 51 0.046
240
FCT001 Factor Viii Deficiency 51 0.046
241
ESP002 Esophageal Varix 51 0.046
242
HYP081 Hypolipoproteinemia 51 0.046
243
HMG002 Hemoglobinuria 50 0.046
244
DNT045 Dental Anomalies and Short Stature 49 0.046
245
c LKM056 Leukemia, Chronic Lymphocytic 2 48 0.046
246
P LYM024 Lymphatic System Disease 48 0.046
247
TBR011 Tuberculous Meningitis 48 0.046
248
P BRB001 Beriberi 46 0.046
249
CMP090 Complement Component 3 Deficiency, Autosomal Recessive 45 0.046
250
IMM136 Immune System Disease 45 0.046
251
KWS001 Kwashiorkor 44 0.046
252
TRP009 Triple X Syndrome 42 0.046
253
c BDY007 Body Mass Index Quantitative Trait Locus 1 42 0.046
254
PYR004 Pyuria 40 0.046
255
ADS004 Aids Dementia Complex 40 0.046
256
ANG049 Angioedema Induced by Ace Inhibitors 40 0.046
257
CRP033 Corpus Callosum, Agenesis of, with Abnormal Genitalia 39 0.046
258
c HYP555 Hypertriglyceridemia, Transient Infantile 39 0.046
259
SCH060 Schistosoma Mansoni Infection, Susceptibility/ 39 0.046
260
SPS019 Spastic Paraparesis 38 0.046
261
c ACR092 Aicardi-Goutieres Syndrome 5 38 0.046
262
ATM052 Autoimmune Disease 1 37 0.046
263
c ACR090 Aicardi-Goutieres Syndrome 2 36 0.046
264
P AXN001 Axonal Neuropathy 36 0.046
266
c BLR024 Biliary Cirrhosis, Primary, 1 30 0.046
267
ACT162 Acute Sensory Ataxic Neuropathy 26 0.046
268
CRT084 Creatinine Clearance Quantitative Trait Locus 25 0.046
269
CNG101 Congenital Human Immunodeficiency Virus 18 0.046
270
HPT075 Hepatitis B Reinfection Following Liver Transplantation 6 0.046
271
P BRS047 Breast Cancer 97 0.032
272
ESP021 Esophageal Cancer 90 0.032
273
c AMY091 Amyotrophic Lateral Sclerosis 1 89 0.032
274
MYL069 Myeloma, Multiple 85 0.032
275
RNL114 Renal Cell Carcinoma, Nonpapillary 78 0.032
276
P LNG064 Lung Cancer Susceptibility 3 78 0.032
277
P RSP003 Respiratory Failure 74 0.032
278
SVR004 Severe Combined Immunodeficiency 73 0.032
279
PLM129 Pulmonary Disease, Chronic Obstructive 73 0.032
280
c SPN225 Spondyloarthropathy 1 73 0.032
281
c LKM063 Leukemia, Chronic Myeloid 72 0.032
282
P SRC025 Sarcoidosis 1 70 0.032
283
MYL009 Myelodysplastic Syndrome 70 0.032
284
CNG034 Congestive Heart Failure 69 0.032
285
P ART022 Arthritis 69 0.032
286
SVR097 Severe Cutaneous Adverse Reaction 69 0.032
287
CRB037 Cerebral Palsy 69 0.032
288
P HYP086 Hypothyroidism 69 0.032
289
P LKM062 Leukemia, Acute Lymphoblastic 69 0.032
290
P CRD119 Cardiac Arrest 67 0.032
291
P NSP012 Nasopharyngeal Carcinoma 66 0.032
292
HYP056 Hypoglycemia 66 0.032
293
c MCL013 Mucolipidosis Iv 66 0.032
294
P PLM036 Pulmonary Fibrosis 65 0.032
295
P DYS154 Dystonia 65 0.032
296
P MTR014 Motor Neuron Disease 65 0.032
297
ATH013 Atherosclerosis Susceptibility 65 0.032
298
PRT036 Peritonitis 64 0.032
299
PLM031 Poliomyelitis 64 0.032
300
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.032
301
P BLD124 Bleeding Disorder, Platelet-Type, 11 63 0.032
302
P HYP069 Hyperparathyroidism 63 0.032
303
c ATM011 Autoimmune Hepatitis 63 0.032
304
HMT002 Hematologic Cancer 62 0.032
305
INT002 Intermittent Claudication 61 0.032
306
P THR005 Thrombotic Thrombocytopenic Purpura 61 0.032
307
P ENC004 Encephalitis 61 0.032
308
RCT015 Reactive Arthritis 61 0.032
309
GST033 Gestational Diabetes 61 0.032
310
P LPS004 Lupus Erythematosus 61 0.032
311
P HMN010 Hemangioma 61 0.032
312
P MYL006 Myeloid Leukemia 60 0.032
313
HRP004 Herpes Zoster 60 0.032
314
P TXP001 Toxoplasmosis 60 0.032
315
INT066 Interstitial Lung Disease 60 0.032
316
LNG099 Lung Disease 60 0.032
317
SQM006 Squamous Cell Carcinoma 60 0.032
318
CHC001 Chickenpox 60 0.032
319
HYD002 Hydronephrosis 60 0.032
320
P THL005 Thalassemia 60 0.032
321
P OPT006 Optic Nerve Disease 60 0.032
322
IDP011 Idiopathic Interstitial Pneumonia 59 0.032
323
PRT058 Pure Autonomic Failure 59 0.032
324
VSL002 Visual Epilepsy 59 0.032
325
GST045 Gastroenteritis 59 0.032
326
c ACT073 Acute Leukemia 58 0.032
327
ADL030 Adult-Onset Still's Disease 58 0.032
328
P CND004 Candidiasis 58 0.032
329
CHL067 Cholecystitis 57 0.032
330
P END033 Endocarditis 57 0.032
331
CYT008 Cytomegalovirus Infection 57 0.032
332
P FBR017 Fibrosarcoma 56 0.032
333
P SZR006 Seizure Disorder 56 0.032
334
ALL010 Allergic Contact Dermatitis 56 0.032
335
SBC001 Subacute Sclerosing Panencephalitis 56 0.032
336
LMB062 Limb Ischemia 55 0.032
337
MMB001 Membranoproliferative Glomerulonephritis 55 0.032
338
P ANT006 Antiphospholipid Syndrome 55 0.032
339
P SBS003 Substance Abuse 55 0.032
340
HRY003 Hairy Cell Leukemia 55 0.032
341
VGN023 Vaginitis 54 0.032
342
AMY027 Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1 54 0.032
343
P LTR001 Lateral Sclerosis 54 0.032
344
LYM040 Lymphoblastic Lymphoma 54 0.032
345
PPL022 Papilloma 54 0.032
346
PNC001 Pancytopenia 54 0.032
347
c PRM092 Primary Lateral Sclerosis, Adult, 1 53 0.032
348
INF034 Infective Endocarditis 53 0.032
349
P CTN003 Cutaneous Lupus Erythematosus 53 0.032
350
HYP063 Hypersplenism 53 0.032
351
c MCR113 Microvascular Complications of Diabetes 3 52 0.032
352
RTN193 Retinitis Pigmentosa and Erythrocytic Microcytosis 52 0.032
353
NRT004 Neuritis 52 0.032
354
P CNG499 Congenital Anomalies of Kidney and Urinary Tract 2 52 0.032
355
c ACT135 Acute Graft Versus Host Disease 52 0.032
356
SPN051 Spondylitis 51 0.032
357
THR004 Thrombocytosis 51 0.032
358
P OVR082 Overgrowth Syndrome 50 0.032
359
PRT018 Portal Vein Thrombosis 50 0.032
360
MLL001 Molluscum Contagiosum 50 0.032
361
MTB004 Metabolic Acidosis 50 0.032
362
SYS003 Systolic Heart Failure 49 0.032
363
PRN014 Paronychia 49 0.032
364
c FLL041 Follicular Lymphoma 1 49 0.032
365
DDN006 Duodenitis 49 0.032
366
URM002 Uremia 49 0.032
367
EBL001 Ebola Hemorrhagic Fever 49 0.032
368
WTH001 Withdrawal Disorder 48 0.032
369
EVN001 Evans' Syndrome 48 0.032
370
CRY004 Cryoglobulinemia 48 0.032
371
SPL018 Splenomegaly 48 0.032
372
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 48 0.032
373
P HMN032 Human Herpesvirus 8 47 0.032
374
c MCR120 Microvascular Complications of Diabetes 7 47 0.032
375
P CLL015 Collagen Disease 47 0.032
376
RTC005 Reticulosarcoma 47 0.032
377
CHR074 Choriocarcinoma 47 0.032
378
SQM002 Squamous Cell Papilloma 46 0.032
379
RTN179 Retinal Arteries, Tortuosity of 44 0.032
380
P SDR002 Siderosis 44 0.032
381
HPT067 Hepatocellular Adenoma 44 0.032
382
P BCL004 B-Cell Non-Hodgkin Lymphoma 44 0.032
383
P RPD001 Rapidly Progressive Glomerulonephritis 44 0.032
384
DRG002 Drug-Induced Hepatitis 43 0.032
385
c ATS307 Autosomal Recessive Cerebellar Ataxia 42 0.032
386
MNN002 Mononeuritis Multiplex 41 0.032
387
c MCR130 Microvascular Complications of Diabetes 6 41 0.032
388
c MCR133 Microvascular Complications of Diabetes 4 41 0.032
389
SPN362 Spondylometaphyseal Dysplasia, Sedaghatian Type 41 0.032
390
c CHR682 Chronic Bilirubin Encephalopathy 39 0.032
391
P FML355 Familial Intrahepatic Cholestasis 38 0.032
392
HYP114 Hypertensive Nephropathy 36 0.032
393
c BNM018 Bone Mineral Density Quantitative Trait Locus 3 33 0.032
394
c SBC035 Subacute Cutaneous Lupus Erythematosus 32 0.032
395
HPT085 Hepatitis, Fulminant Viral 32 0.032
396
INF009 Inflammatory Spondylopathy 31 0.032
397
CYT004 Cytomegalic Inclusion Disease 31 0.032
399
PHT004 Photoallergic Dermatitis 28 0.032
400
CTN019 Cutaneous Polyarteritis Nodosa 27 0.032
401
HML018 Homologous Wasting Disease 22 0.032
402
IMM085 Immunodeficiency 25 21 0.032
403
c CHR465 Chronic Diarrhea Due to Guanylate Cyclase 2c Overactivity 21 0.032
404
IND005 Indolent B Cell Lymphoma 20 0.032
405
CD4008 Cd4/cd8 T-Cell Ratio 20 0.032
406
MYS002 Myositis Fibrosa 19 0.032
407
IMM165 Immunoglobulin Switch Sequences 15 0.032
Content
Loading form....